Reicin Alise

Reicin Alise is listed in filings as Director at Sana Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Sana Biotechnology, Inc. (SANA) and Tectonic Therapeutic, Inc. (TECX). The current snapshot covers public activity from Jun 24, 2024 to Jun 5, 2026. Reported amounts are shown as $266.4K to $52.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.